Evidence map›Paper›PMID 33495715›Full record

ArticleScience bulletin2021

SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production.

Lingling Luo, Zhean Li, Tiejun Zhao, Xiaohui Ju, Peixiang Ma, Boxing Jin, Yulin Zhou, Su He, Jinhua Huang, Xun Xu and 10 more

Open access · greenAbstract read
In one paragraph

Article in Science bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Lingling LuoSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Zhean LiSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Tiejun ZhaoCollege of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Xiaohui JuCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China.
Peixiang MaShanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.
Boxing JinCollege of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Yulin ZhouCollege of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Su HeCollege of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Jinhua HuangCollege of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Xun XuCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China.
Yan ZouShanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.
Ping LiDepartment of Hematology, Tongji Hospital of Tongji University, Shanghai 200065, China.
Aibin LiangDepartment of Hematology, Tongji Hospital of Tongji University, Shanghai 200065, China.
Jia LiuShanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.
Tian ChiSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Xingxu HuangSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Qiang DingCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 100084, China.
Zhigang JinCollege of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Cheng HuangSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Yu ZhangSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
ShanghaiTech University · CNZhejiang Normal University · CNTongji University · CNTsinghua University · CNBeijing Advanced Sciences and Innovation Center · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key to tackling the coronavirus disease 2019 (COVID-19) pandemic is to understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) manages to outsmart host antiviral defense mechanisms. Stress granules (SGs), which are assembled during viral infection and function to sequester host and viral mRNAs and proteins, are part of the antiviral responses. Here, we show that the SARS-CoV-2 nucleocapsid (N) protein, an RNA binding protein essential for viral production, interacted with Ras-GTPase-activating protein SH3-domain-binding protein (G3BP) and disrupted SG assembly, both of which require intrinsically disordered region1 (IDR1) in N protein. The N protein partitioned into SGs through liquid-liquid phase separation with G3BP, and blocked the interaction of G3BP1 with other SG-related proteins. Moreover, the N protein domains important for phase separation with G3BP and SG disassembly were required for SARS-CoV-2 viral production

Indexed as

G3BPLiquid-liquid phase separationNucleocapsid proteinSARS-CoV-2Stress granulesViral production

Identifiers

PMID33495715
PMCPMC7816596
OpenAlexW3125358417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.